The first year of treatment predicts the prognosis of asthma over 25 y-A prospective study.
adult asthma long-term follow-up
asthma control
asthma remission
health-related quality of life
predicted value of lung function
Journal
Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
03
02
2019
revised:
22
05
2019
accepted:
24
05
2019
pubmed:
16
7
2019
medline:
12
1
2021
entrez:
16
7
2019
Statut:
ppublish
Résumé
An investigator-driven, real-life follow-up study of adult-onset steroid-naïve, newly diagnosed asthma (162 patients) to investigate the treatment results over the 25-year course of the disease and whether the first treatment year's forced expiratory volume in one second (FEV Eighty-three per cent of the 133 living patients participated in the 25-year examinations. At this visit, basic asthma examinations including lung function, as well as questionnaires for health-related quality of life (HRQoL), GINA and the Asthma Control Test, were used for evaluation. The use of medication and remission was verified. There was no statistically significant change in mean FEV In adult-onset asthma, the level of FEV
Sections du résumé
BACKGROUND
An investigator-driven, real-life follow-up study of adult-onset steroid-naïve, newly diagnosed asthma (162 patients) to investigate the treatment results over the 25-year course of the disease and whether the first treatment year's forced expiratory volume in one second (FEV
METHODS
Eighty-three per cent of the 133 living patients participated in the 25-year examinations. At this visit, basic asthma examinations including lung function, as well as questionnaires for health-related quality of life (HRQoL), GINA and the Asthma Control Test, were used for evaluation. The use of medication and remission was verified.
RESULTS
There was no statistically significant change in mean FEV
CONCLUSION
In adult-onset asthma, the level of FEV
Substances chimiques
Anti-Asthmatic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
75-83Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Références
Global strategy for asthma Management and Prevention, Global Initiative for Asthma (Gina) 2008, Report Updated 2008. http://www.ginasthma.org/.
Global Initiative for Asthma. 2017 GINA report. Global strategy for asthma Management and Prevention, 2017. http.//ginasthma/org/2017-gina-report-strategy-for-asthma-management-and-prevention/. Access June 6, 2017.
Kauppinen R, Vilkka V, Hedman J, Sintonen H. Ten-year follow-up early intensive self-management guidance in newly diagnosed patients with asthma. J Asthma. 2011;48:945-951.
Tuomisto LE, Ilmarinen P, Niemelä O, Haanpää J, Kankaanranta T, Kamkaanranta H. A 12-year prognosis of adult-onset asthma: Seinäjoki Adult Asthma Study. Respir Med. 2016;117:223-239.
O’Byrne PM, Pedersen S, Busse WW, et al. Effect of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest. 2006;129:1478-1485.
Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med. 1994;150:629-634.
Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilator function in adults with asthma. N Engl J Med. 1998;339:1194-1200.
Shimoda T, Obase Y, Kishikawa R, Iwanaga T. Impact of inhaled corticosteroid treatment on 15-year longitudinal respiratory function changes in adult patients with bronchial asthma. Int Arch Allergy Immunol. 2013;162:323-329.
Porpodis K, Papakosta D, Manika K, et al. Long-term prognosis of asthma is good- a 12-year follow-up study. Influence of treatment J Asthma 2009;46:625-631.
Haahtela T, Tamminen K, Kava T, et al. Thirteen year follow-up of early intervention with inhaled corticosteroid in patients with asthma. J Allergy Clin Immunol. 2009;124:1180-1185.
Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391:783-800.
Bidal N, Barnes N, Griffiths C, Horne R. Understanding patients’ perceptions of asthma control: a qualitative study. Eur Respir J. 2018;51(6):1701346.
Haughney J, Barnes G, Partridge M, Cleland J. The Living & Breathing Study: a study of patients’ views of asthma and its treatment. Prim Care Respir J. 2004;13:28-35.
Guidelines to the diagnosis and treatment of asthma. Am Rev Respir Dis. 1987;136:225-244.
Kauppinen R, Vilkka V, Sintonen H, Tukiainen H. One-year economic evaluation of intensive vs conventional patient education and supervision for self-management of new asthmatic patients. Respir Med. 1998;92:300-307.
Viljanen AA, Halttunen PK, Kreus K-E, Viljanen BC. Spirometric Studies in Non-Smoking, Healthy Adults. Scand J Clin Lab Invest 1982;42(sup159):5-20.
Kauppinen R, Vilkka V, Hedman J. Is the first treatment years crucial for the prognosis of newly diagnosed adult onset asthma patients? Ten-year follow-up study. Suom LääkL. 2016;29-35.
Sintonen H, Pekurinen M. A generic 15-dimensional measure of health-related quality of life (15D). J Soc Med. 1989;26:85-96.
Jones PW, Quirk FH, Baveystock CM. The St George’s respiratory questionnaire. Respir Med. 1991;85:25-31.
Quirk F, Baveystock C, Wilson R, Jones P. Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries. Eur Respir J. 1991;4:167-171.
Alanne S, Roine R, Räsänen P, Vainiola T, Sintonen H. Estimating the minimum important change in the 15D scores. Qual Life Res. 2015;24:599-606.
Aromaa A, Koskinen S. eds. Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey 2004. Helsinki Finland: Publication of the National Public Health Institute. 2004. B12/2004.
Schatz M, Sorkness CA, Li JT, et al. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialist. J Allergy Clin Immunol. 2006;117:549-556.
Schatz M, Kosinski M, Yarlas AS, Hanlon J, Watson ME, Jhingran P. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol. 2009;124:719-723.
Ministry of Social Affairs and Health. Asthma programme in Finland 1994-2004. Working group report. Clin Exp Allergy. 1996;26:11-24.
Tanaka A, Jinno M, Hirai K, et al. Longitudinal increase in total IgE levels in patients with adult asthma: an association with poor asthma control. Respiratory Res. 2014;15:144-151.
Jarvis D, Luczynska C, Chinn S, et al. Change in prevalence of IgE sensitization and mean total IgE with age and cohort. J Allergy Clin Immunol. 2005;116:675-682.
Ali Z, Dirks CG, Ulrik CS. Long-term mortality among adults with asthma: a 25-year follow-up of 1,075 outpatients with asthma. Chest. 2013;143:1649-1655.
Lemmetyinen RE, Karjalainen JV, But A, et al. Higher mortality of adults with asthma: A 15-year follow-up of a population-based cohort. Allergy. 2018;73:1479-1488.
Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006;61:105-110.
Tommola M, Ilmarinen P, Tuomisto LE, et al. The effect of smoking on lung function: a clinical study of adult-asthma. Eur Respir J. 2016;48:1298-1306.
Thomson NC. Asthma and smoking-induced airway disease without spirometric COPD. Eur Respir J. 2017;49:1602061.
Cerveri I, Cazzoletti L, Corsico AG, et al. The impact of cigarette smoking on asthma: a population-based international cohort study. Int Arch Allergy Immunol. 2012;158:175-183.
Stapleton M, Howard-Thomson A, George C, Hoover MN, Self TH. Smoking and asthma. J Am Board Fam Med. 2011;24:313-322.
van Schayck OC, Haughney J, Aubier M, et al. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of open label study. Respir Med. 2012;106:189-196.
Polosa R, Russo C, Caponnetto P, et al. Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study. Respir Res. 2011;12:16.
Vähätalo I, Ilmarinen P, TuomistoLE NO, Kankaanranta H. Inhaled corticosteroid and asthma control in adult-onset asthma: 12-year follow-up study. Respir Med. 2018;137:70-76.
Papi A, Ryan D, Soriano JB, et al. Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate-to-severe asthma. J Allergy Clin Immunol Pract. 2018;6:1989-1998.
Wenzel SE. Complex phenotypes in asthma: current definitions. Pulm Pharmacol Ther. 2013;26:710-715.
Melosini L, Dente FL, Bacci E, et al. Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control. J Asthma. 2012;49:31-323.
Schatz M, Zeiger RS, Yang S-J, et al. Change in asthma control over time: predictors and outcomes. J Allergy Clin Immunol Pract. 2014;2:59-64.
Aaron SD, Vandemheen KL, FitzGerald JM, et al. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317:269-279.
Selroos O, Pietinalho A, Riska H. Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: real-life study. Respir Med. 2004;98:254-262.
Westerhof GA, Coumou H, de Nijs SB, Weersink EJ, Bel EH. Clinical predictors of remission and persistence of adult-onset asthma. J Allergy Clin Immunol. 2018;141:104-109.
Cazzoletti L, Corsico AG, Albicini F, et al. The course of asthma in young adults: a population-based nine-year follow-up on asthma remission and control. PLoS ONE. 2014;29:e86956.
Miedinger D, Neukomm E, Chhajed PN, et al. The use of the Asthma Control Test in general practice and its correlation with asthma control according to the GINA guidelines. Curr Med Res Opin. 2011;12:2301-2308.
Jia CE, Zhang HP, Lv Y, et al. The asthma control test and asthma control questionnaire for assessing asthma control: systematic review and meta-analysis. J Allergy Clin Immunol. 2013;131:695-703.